These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

559 related items for PubMed ID: 12669465

  • 1. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
    Dietrich G, Spreng S, Favre D, Viret JF, Guzman CA.
    Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465
    [Abstract] [Full Text] [Related]

  • 2. Use of attenuated bacteria as delivery vectors for DNA vaccines.
    Daudel D, Weidinger G, Spreng S.
    Expert Rev Vaccines; 2007 Feb; 6(1):97-110. PubMed ID: 17280482
    [Abstract] [Full Text] [Related]

  • 3. Bacterial systems for the delivery of eukaryotic antigen expression vectors.
    Dietrich G, Spreng S, Gentschev I, Goebel W.
    Antisense Nucleic Acid Drug Dev; 2000 Oct; 10(5):391-9. PubMed ID: 11079578
    [Abstract] [Full Text] [Related]

  • 4. Current status and future perspectives of DNA vaccine delivery by attenuated intracellular bacteria.
    Dietrich G.
    Arch Immunol Ther Exp (Warsz); 2000 Oct; 48(3):177-82. PubMed ID: 10912622
    [Abstract] [Full Text] [Related]

  • 5. Plasmid maintenance systems suitable for GMO-based bacterial vaccines.
    Spreng S, Viret JF.
    Vaccine; 2005 Mar 18; 23(17-18):2060-5. PubMed ID: 15755571
    [Abstract] [Full Text] [Related]

  • 6. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.
    Loeffler DI, Schoen CU, Goebel W, Pilgrim S.
    Infect Immun; 2006 Jul 18; 74(7):3946-57. PubMed ID: 16790768
    [Abstract] [Full Text] [Related]

  • 7. Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet?
    Lewis GK.
    Expert Rev Vaccines; 2007 Jun 18; 6(3):431-40. PubMed ID: 17542757
    [Abstract] [Full Text] [Related]

  • 8. Recent advances in the development of live, attenuated bacterial vectors.
    Roland KL, Tinge SA, Killeen KP, Kochi SK.
    Curr Opin Mol Ther; 2005 Feb 18; 7(1):62-72. PubMed ID: 15732531
    [Abstract] [Full Text] [Related]

  • 9. Bacteria as DNA vaccine carriers for genetic immunization.
    Schoen C, Stritzker J, Goebel W, Pilgrim S.
    Int J Med Microbiol; 2004 Oct 18; 294(5):319-35. PubMed ID: 15532991
    [Abstract] [Full Text] [Related]

  • 10. Transfer of eukaryotic expression plasmids to mammalian hosts by attenuated Salmonella spp.
    Weiss S.
    Int J Med Microbiol; 2003 Apr 18; 293(1):95-106. PubMed ID: 12755370
    [Abstract] [Full Text] [Related]

  • 11. Attenuated salmonella and Shigella as carriers for DNA vaccines.
    Xu F, Ulmer JB.
    J Drug Target; 2003 Apr 18; 11(8-10):481-8. PubMed ID: 15203916
    [Abstract] [Full Text] [Related]

  • 12. Intracellular bacteria as targets and carriers for vaccination.
    Mollenkopf H, Dietrich G, Kaufmann SH.
    Biol Chem; 2001 Apr 18; 382(4):521-32. PubMed ID: 11405217
    [Abstract] [Full Text] [Related]

  • 13. Plasmid DNA and viral vector-based vaccines for the treatment of cancer.
    Anderson RJ, Schneider J.
    Vaccine; 2007 Sep 27; 25 Suppl 2():B24-34. PubMed ID: 17698262
    [Abstract] [Full Text] [Related]

  • 14. Improving live attenuated bacterial carriers for vaccination and therapy.
    Loessner H, Endmann A, Leschner S, Bauer H, Zelmer A, zur Lage S, Westphal K, Weiss S.
    Int J Med Microbiol; 2008 Jan 27; 298(1-2):21-6. PubMed ID: 17702649
    [Abstract] [Full Text] [Related]

  • 15. Bacteria-mediated transfer of eukaryotic expression plasmids into mammalian host cells.
    Weiss S, Krusch S.
    Biol Chem; 2001 Apr 27; 382(4):533-41. PubMed ID: 11405218
    [Abstract] [Full Text] [Related]

  • 16. Advances in the development of bacterial vector technology.
    Kochi SK, Killeen KP, Ryan US.
    Expert Rev Vaccines; 2003 Feb 27; 2(1):31-43. PubMed ID: 12901595
    [Abstract] [Full Text] [Related]

  • 17. Oral delivery of DNA vaccine encoding VP28 against white spot syndrome virus in crayfish by attenuated Salmonella typhimurium.
    Ning JF, Zhu W, Xu JP, Zheng CY, Meng XL.
    Vaccine; 2009 Feb 11; 27(7):1127-35. PubMed ID: 19071178
    [Abstract] [Full Text] [Related]

  • 18. Listeria monocytogenes as novel carrier system for the development of live vaccines.
    Schoen C, Loeffler DI, Frentzen A, Pilgrim S, Goebel W, Stritzker J.
    Int J Med Microbiol; 2008 Jan 11; 298(1-2):45-58. PubMed ID: 17936682
    [Abstract] [Full Text] [Related]

  • 19. [Attenuated Salmonella typhimurium as DNA delivery vehicle for DNA-mediated immunization].
    He P, Chen H, Liu JX, Chen SY, Hu BY.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep 11; 18(3):238-42. PubMed ID: 15640857
    [Abstract] [Full Text] [Related]

  • 20. Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli.
    Zhu C, Ruiz-Perez F, Yang Z, Mao Y, Hackethal VL, Greco KM, Choy W, Davis K, Butterton JR, Boedeker EC.
    Vaccine; 2006 May 01; 24(18):3821-31. PubMed ID: 16098637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.